Skip to content

iRhythm Holdings, Inc. IRTC Interest coverage

Interest coverage at other companies

Baxter International logo
Baxter InternationalBAX
-1×-1.8×
Boston Scientific logo
Boston ScientificBSX
10.6×+1.7×
ITG
Integer HoldingsITGR
5.3×+1.5×
Merit Medical Systems logo
Merit Medical SystemsMMSI
7.1×+1.7×
Medtronic logo
MedtronicMDT
9.1×+0.9×
Abbott logo
AbbottABT
14.4×+1.4×

Other financials

Income statement

See full
Revenue$199.4M+25.7%
Gross profit$141.4M+29.4%
Operating income-$16.2M+50.3%
Net income-$13.9M+54.6%
EPS (diluted)-$0.43+55.7%

Balance sheet

See full
Cash & equivalents$248.5M-35.2%
Total debt$79.0M-10.5%
Total equity$161.2M+86.0%
Total assets$1.0B+8.7%

Cash flow

See full
Operating cash flow-$26.2M-232%
CapEx$6.9M-26.7%
Free cash flow-$33.1M-91.1%

Valuation

See full
Market cap$3.62B+16.0%

Profitability

See full
Gross margin71%+1.6pp
Operating margin-5.5%-2.2pp
Net margin-7.3%-3.1pp
FCF margin2.4%

Returns & leverage

See full
Return on equity-53.1%-17.4pp
Debt / equity0.5×-0.5×
Current ratio5.2×-0.5×

Where this comes from

Calculated from iRhythm Holdings, Inc. ’s reported figures.

Based on trailing twelve months.

The official record: iRhythm Holdings, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRhythm Holdings, Inc. 's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRhythm Holdings, Inc. 's interest coverage?
iRhythm Holdings, Inc. (IRTC) reported interest coverage of -3.3× in Q1 2026.
How has iRhythm Holdings, Inc. 's interest coverage changed year-over-year?
iRhythm Holdings, Inc. 's interest coverage increased by 60.4% year-over-year, from -8.3× to -3.3×.
What is the long-term trend for iRhythm Holdings, Inc. 's interest coverage?
Over 5 years (2020 to 2025), iRhythm Holdings, Inc. 's interest coverage has grown at a -30.9% compound annual growth rate (CAGR), from -28.8× to -4.5×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.